<ѻý>Cognitively Healthy Centenarians; Seizures and COVID Vax; New AAN Statementѻý> News and commentary from the world of neurology and neuroscience Apr 30, 2024
<ѻý>Closing Gender-Based Disease Disparities Starts in the Labѻý> Women must have a seat at the table in deciding what type of research to pursue Apr 27, 2024
<ѻý>Alzheimer's Drug Skepticism; Safeguarding Brain Data; Benefits of Stimulating Jobsѻý> News and commentary from the world of neurology and neuroscience Apr 23, 2024
<ѻý>Novel Drug Made of Gold Nanocrystals Appears Safe in Multiple Sclerosisѻý> Small study suggested benefits for MS patients with chronic optic neuropathy Apr 22, 2024
<ѻý>Multiple Sclerosis Predicted by Autoantibody Signatureѻý> Blood samples reveal signs of MS years before clinical diagnosis Apr 19, 2024
<ѻý>Ocrelizumab Trial Fills Research Gap for Black, Hispanic MS Patientsѻý> Half of patients had no evidence of disease activity at 48 weeks Apr 18, 2024
<ѻý>The Dying Brain; Obesity Drugs and MS; NurOwn Tries Againѻý> News and commentary from the world of neurology and neuroscience Apr 09, 2024
<ѻý>Caffeine and Parkinson's; Brutally Honest Look at Dementia; Three MS Subtypesѻý> News and commentary from the world of neurology and neuroscience Apr 02, 2024
<ѻý>Stopping High-Efficacy MS Drugs Raises Relapse Risk for Older Patientsѻý> Discontinuing natalizumab and fingolimod carried highest risk Mar 27, 2024
<ѻý>Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessedѻý> News and commentary from the world of neurology and neuroscience Mar 19, 2024
<ѻý>Viagra and Alzheimer's; Migraine Consensus Statement; FDA Updates Drug Guidanceѻý> News and commentary from the world of neurology and neuroscience Mar 12, 2024
<ѻý>Breastfeeding While Taking MS Monoclonal Antibody Drugs Appears Safeѻý> No negative effects on early infant development or health seen Mar 11, 2024
<ѻý>BTK Inhibitor Fails to Eliminate Paramagnetic Rim Lesions in MSѻý> Higher tolebrutinib dose, longer treatment duration may be needed Mar 07, 2024
<ѻý>Evobrutinib Fails to Beat Teriflunomide in Relapsing MSѻý> No efficacy difference between the two drugs in two phase III trials Mar 06, 2024
<ѻý>Lucid Moments in Late Dementia; Seizure Dogs and Epilepsy; Wildfire Smoke Effectsѻý> News and commentary from the world of neurology and neuroscience Mar 05, 2024
<ѻý>Cognitive Decline in MS Predicted by Paramagnetic Rim Lesionsѻý> Processing speed scores lower 4 years later for people with one or more baseline lesions Mar 04, 2024
<ѻý>Ozanimod Controls MS Disease Activity Regardless of Ageѻý> Clinical, radiologic measures remained stable or improved in both younger and older patients Mar 03, 2024
<ѻý>Long COVID May Be Difficult to Identify in MSѻý> Tough to pinpoint what is a long-term MS symptom and what is a long COVID symptom Mar 02, 2024
<ѻý>Obesity Associated With Faster MS Disease Progressionѻý> Increased risk of physical, psychological, cognitive decline Mar 02, 2024
<ѻý>Leaky Blood Vessels and Long COVID; BCG Vaccine and Alzheimer's; New CTE Subtypeѻý> News and commentary from the world of neurology and neuroscience Feb 27, 2024
<ѻý>Herpes-Dementia Link; How COVID Affects the Brain; FDA to Decide on Duchenne Drugѻý> News and commentary from the world of neurology and neuroscience Feb 20, 2024
<ѻý>Highly Effective Therapies Early in Pediatric MS Linked to Reduced Relapse Riskѻý> Study supports starting kids on high-efficacy drugs, but long-term safety studies are crucial Feb 16, 2024
<ѻý>Novel Anti-CD40L Antibody Slows New Brain Lesions in Relapsing MSѻý> Frexalimab shows promise in phase II study Feb 14, 2024
<ѻý>When Does Brain Death Occur? Parkinson's-Paraquat Links; AI Boosts ARIA Detectionѻý> News and commentary from the world of neurology and neuroscience Feb 13, 2024
<ѻý>Can the Eye Reveal Cardiac and Lung Disease -- Plus Much More?ѻý> Researchers link thinner retinal layers to higher risk of multiple diseases Jan 26, 2024
<ѻý>Unusual Visual Symptoms and Alzheimer's; Infections and Dementia; Head Trauma and MSѻý> News and commentary from the world of neurology and neuroscience Jan 23, 2024
<ѻý>MS Risk Linked to Ancient Migrationsѻý> Findings may help demystify multiple sclerosis Jan 10, 2024
<ѻý>What Super-Agers Show; Epstein-Barr and Early MS; Five Variants of Alzheimer'sѻý> News and commentary from the world of neurology and neuroscience Jan 09, 2024
<ѻý>Neurologic Disabilities Linked to Long COVID Risksѻý> Certain persistent symptoms more likely compared with other COVID patients Jan 04, 2024
<ѻý>Midlife Alzheimer's Biomarker; How Measles Spread in the Brain; MS and HIVѻý> News and commentary from the world of neurology and neuroscience Dec 26, 2023
<ѻý>Ozanimod Did Not Appear to Lead to More Adverse Pregnancy Outcomesѻý> However, avoiding pregnancy when on the IBD/MS drug still advised Dec 19, 2023
<ѻý>Twins and Dementia; CRISPR and Alzheimer's; BTK Inhibitor Fails in MS Trialsѻý> News and commentary from the world of neurology and neuroscience Dec 12, 2023
<ѻý>Personality Predictors of Dementia; Parkinson's Blood Test; Klotho in Alzheimer'sѻý> News and commentary from the world of neurology and neuroscience Dec 05, 2023
<ѻý>Progression Independent of Relapse Activity in Pediatric-Onset MSѻý> Early treatment with disease-modifying therapy may offer some protection Nov 29, 2023
<ѻý>Alzheimer's Vaccines Are Back; Streamlining Prior Authorization; Rare APOE Variantѻý> News and commentary from the world of neurology and neuroscience Nov 21, 2023
<ѻý>Developing a Consensus on Smoldering MSѻý> Experts aim to develop a deeper understanding of what smoldering disease entails Nov 21, 2023
<ѻý>High NfL Levels Predict Greater MS Disability Within 2 Yearsѻý> Temporal relationship is a critical insight, says Ahmed Abdelhak, MD Nov 20, 2023
<ѻý>A Novel Mechanism of Action in Treating Relapsing MSѻý> Our panel of experts discuss frexalimab Nov 17, 2023 video
<ѻý>Handheld Device Detects Alzheimer's Biomarkers; Long COVID Smell Loss; MS Fatigueѻý> News and commentary from the world of neurology and neuroscience Nov 14, 2023
<ѻý>New Data on CD40 Ligand Inhibitor for Relapsing MSѻý> Novel agent led to sustained reduction of new lesions at 24 weeks Nov 14, 2023 video